Radiopharmaceutical Research and Development Hubs
The UK is a global leader in radiochemistry research, with major hubs located at institutions like University College London (UCL) and King’s College London. These centers house specialized labs where scientists develop novel tracers to target specific diseases, such as Alzheimer's or rare forms of hypertension.
These R&D hubs often feature Imaging Clinical Research Facilities (CRFs), which act as a bridge between the laboratory and the hospital. They allow for "first-in-human" trials where new radioactive agents are tested for the first time. The Medicines Discovery Catapult (MDC) also plays a significant role, providing the infrastructure and expertise needed to turn laboratory breakthroughs into commercially viable medicines.
1 visualização